🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to compare the analgesic activity of capsaicin patch 8% app...
Status
Completed
Location
INSTITUT DE CANCEROLOGIE DE L'OUEST (ICO) Site Angers
Start Date
2021-04-28
Trial ID
NCT04704453
Treatments Being Tested
This is a Phase 1b study involving multiple oral doses of AV-101 in healthy...
Status
Completed
Location
UCSD Medical Center
Start Date
2011-12
Trial ID
NCT01483846
The purpose of this research study is to test cough function in individuals...
Status
Completed
Location
Center for Movement Disorders and Neurorestoration
Start Date
2014-10
Trial ID
NCT02183519
Treatments Being Tested
The Summary of product characteristics (SmPC) for QUTENZA advises that topi...
Status
Completed
Location
Site 102
Start Date
2011-07-06
Trial ID
NCT01416116
Capsiate is a non-pungent analogue of capsaicin, the component of hot peppe...
Status
Completed
Location
Exercise Metabolism Research Laboratory, McMaster Univeristy
Start Date
2008-04
Trial ID
NCT00692601
The effect of peripheral GABAA receptor activation on pain and sensitivity ...
Status
Unknown
Location
Aalborg University
Start Date
2016-10
Trial ID
NCT02928328
Treatments Being Tested
According WHO, oropharyngeal dysphagia (OD) is a prevalent post-stroke (PS)...
Status
Unknown
Location
Hospital de Mataró. Consorci Sanitari del Mareme.
Start Date
2021-07-01
Trial ID
NCT05735626
Treatments Being Tested
Study objectives To establish whether an oral intake of Capsicum oleoresin...
Status
Active Not Recruiting
Location
Allergy clinic, Sahlgrenska University Hospital
Start Date
2019-06-01
Trial ID
NCT04125563
Treatments Being Tested
Burning Mouth Syndrome (BMS) is characterized by a burning sensation on the...
Status
Completed
Location
Federal university of minas gerais
Start Date
2023-11-01
Trial ID
NCT06040190
Recently, a new drug called Gefapixant passed phase III clinical trials for...
Status
Unknown
Location
The University of Melbourne
Start Date
2024-01-01
Trial ID
NCT05813223
Treatments Being Tested